T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues

被引:52
作者
Jungbluth, AA
Iversen, K
Coplan, K
Kolb, D
Stockert, E
Chen, YT
Old, LJ
Busam, K
机构
[1] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA
[2] Cornell Univ, Coll Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
T311; tyrosinase; melanocyte-associated markers;
D O I
10.1016/S0344-0338(00)80072-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Tyrosinase is a key enzyme in melanin biosynthesis and represents a marker of melanocytic differentiation. We previously generated T311 a murine monoclonal antibody body to the tyrosinase recombinant protein. This study was performed to evaluate T311 as a diagnostic immunohistochemical reagent for use on formalin-fixed paraffin embedded pathological material. We analyzed the specificity of the antibody on a panel of normal and neoplastic tissues, and we assessed its sensitivity in a large number of metastatic and primary malignant melanomas, nevi, three angiomyolipomas, and two vitiligo specimens. T311 revealed intense reactivity on paraffin-embedded material. Immunoreactivity was limited to cells of melanocytic differentiation and no immunostaining was present in unrelated normal tissues and tumors. Eighty four percent of metastatic malignant melanomas were immunoreactive with T311 and showed predominantly a homogeneous expression pattern. However, in primary melanomas of the desmoplastic/spindle cell type, T311 revealed a poor immunoreactivity. Nevi showed intense staining at the junctional zone, while the dermal component revealed decreasing reactivity towards deeper areas. Only one angiomyolipoma was focally immunoreactive with T311. Vitiligo specimens were immunonegative. We conclude that T311 is a specific and sensitive marker for the detection of melanocytic lesions in formalin-fixed paraffin-embedded tissues and a useful serological reagent for diagnostic pathology.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 45 条
  • [1] Bacchi CE, 1996, APPL IMMUNOHISTOCHEM, V4, P73
  • [2] BATTYANI Z, 1993, PIGM CELL RES, V6, P400
  • [3] Blessing K, 1998, HISTOPATHOLOGY, V32, P139
  • [4] Tumor antigens
    Boon, T
    Old, LJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) : 681 - 683
  • [5] THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS
    BRICHARD, V
    VANPEL, A
    WOLFEL, T
    WOLFEL, C
    DEPLAEN, E
    LETHE, B
    COULIE, P
    BOON, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 489 - 495
  • [6] Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage
    Brouwenstijn, N
    Slager, EH
    Bakker, ABH
    Schreurs, MWJ
    Van der Spek, CW
    Adema, GJ
    Schrier, PI
    Figdor, CG
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (12) : 1562 - 1566
  • [7] Busam K. J., 1999, Modern Pathology, V12, p56A
  • [8] Melan-A, a new melanocytic differentiation marker
    Busam, KJ
    Jungbluth, AA
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 1999, 6 (01) : 12 - 18
  • [9] Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors
    Busam, KJ
    Iversen, K
    Coplan, KA
    Old, LJ
    Stockert, E
    Chen, YT
    McGregor, D
    Jungbluth, A
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (01) : 57 - 63
  • [10] Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
    Busam, KJ
    Chen, YT
    Old, LJ
    Stockert, E
    Iversen, K
    Coplan, KA
    Rosai, J
    Barnhill, RL
    Jungbluth, AA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) : 976 - 982